Skip to content
pharma stocks canada

Pharma Stocks Canada

Newsletter
Random News
  • Articles
  • Blog
    • 1933 Industries Announces First Quarter 2023 Financial Results and Reports Record Revenue of $5.64 Million
    • A New Tool to Strengthen the Role of Pharmacists in Healthcare
    • Bioengineers have grown a “glove” of skin for transplantation
    • Canadian Pharma Companies
    • Hemab Therapeutics successfully advances the first innovative treatments for rare bleeding disorders
    • How to Invest in Pharma
    • Teijin and Axcelead team up to develop new drugs
    • Teva’s Austedo XR receives FDA approval for tardive dyskinesia
    • The Worldwide Pharmaceutical Industry
  • Pharma Stocks Canada
Headlines
  • Pharma Stocks Canada

    Medical Facilities Corporation Renews Normal Course Issuer Bid – $DR.TO

    31 mins ago
  • Pharma Stocks Canada

    XORTX Meets Nasdaq Continued Listing Requirements – $XRTX.V $XRTX.US

    31 mins ago
  • Pharma Stocks Canada

    TSX Venture Exchange Stock Maintenance Bulletins – $CD.V $CUR.V $HAPB.V $HPQ.V $KLD.V $MARV.V $NXLV.V $RP.V $STMP.V

    8 hours ago
  • Pharma Stocks Canada

    MedMira Reports FY2023 Fourth Quarter and Year End Financial Results – $MIR.V

    9 hours ago
  • Pharma Stocks Canada

    Evolve Announces Estimated Annual Distributions for Certain Evolve Funds – $LIFE.TO $DIVS.TO $MESH.TO $CYBR.TO $HERO.TO $DATA.TO $QQQT.TO $MCAD.TO $ESPX.TO $CALL-B.TO $BASE.TO $HISA.NEO $BOND.TO $ETSX.TO $LEAD.TO $CARS.TO $BASE-B.TO $BANK.TO $ETHR.TO $FIXD.NEO $EDGE.TO $ETC.TO $CALL.TO $EBIT.TO $EARN.TO $CARS-B.TO $EBNK.TO

    11 hours ago
  • Pharma Stocks Canada

    GeneTether Therapeutics Inc. Announces Third Quarter 2023 Financial Results – $GTTX.CN

    12 hours ago
  • Home
  • Articles

Articles

The Role of Pharmacists>>>

A New Tool to Strengthen the Role of Pharmacists in Healthcare.

Pharmaceutical Industry>>>

Over time, investing in the pharmaceutical sector has proven to be a wise decision.

How to Invest in Pharma>>>

Pharma strive to introduce novel remedies to the market.

1933 Industries Announces First Quarter 2023 Financial Results and Reports Record Revenue of $5.64 Million>>>

Hemab Therapeutics successfully advances the first innovative treatments for rare bleeding disorders>>>

Bioengineers have grown a “glove” of skin for transplantation>>>

Teva’s Austedo XR receives FDA approval for tardive dyskinesia>>>

Teijin and Axcelead team up to develop new drugs>>>

Canadian Pharma Companies>>>

Development and Marketing 2023. Powered By Digital Agency.